KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) Non Operating Income (2016 - 2026)

Zimmer Biomet Holdings has reported Non Operating Income over the past 13 years, most recently at -$3.0 million for Q1 2026.

  • For Q1 2026, Non Operating Income fell 203.45% year-over-year to -$3.0 million; the TTM value through Mar 2026 reached $19.6 million, up 169.75%, while the annual FY2025 figure was $25.5 million, 181.99% up from the prior year.
  • Non Operating Income for Q1 2026 was -$3.0 million at Zimmer Biomet Holdings, down from $15.4 million in the prior quarter.
  • Over five years, Non Operating Income peaked at $15.4 million in Q4 2025 and troughed at -$56.1 million in Q1 2022.
  • A 5-year average of -$8.6 million and a median of -$100000.0 in 2024 define the central range for Non Operating Income.
  • Biggest five-year swings in Non Operating Income: tumbled 8566.67% in 2022 and later surged 3000.0% in 2025.
  • Year by year, Non Operating Income stood at -$3.9 million in 2022, then crashed by 402.56% to -$19.6 million in 2023, then plummeted by 94.39% to -$38.1 million in 2024, then skyrocketed by 140.42% to $15.4 million in 2025, then crashed by 119.48% to -$3.0 million in 2026.
  • Business Quant data shows Non Operating Income for ZBH at -$3.0 million in Q1 2026, $15.4 million in Q4 2025, and $3.3 million in Q3 2025.